Newborn Genetic Screening

Newborn Genetic Screening
Titles of the article

Book Your Appointment

Consult with Dr. Ehsan Karimiani
Specialist Clinical Geneticist

Book Now
DNA Icon

What Is Newborn Genetic Screening?

Newborn Genetic Screening is a form of health screening used shortly after birth to identify babies who may have certain inherited, metabolic or other serious conditions before signs or symptoms become apparent. Early identification can help healthcare professionals arrange further assessment, confirm a possible diagnosis and, where appropriate, start treatment or monitoring as soon as possible.

Newborn screening is part of the wider approach to genetic screening programmes, but it is not the same as diagnostic genetic testing. A screening result indicates whether a baby may have an increased likelihood of a particular condition; it does not usually confirm that the condition is present. Further testing may therefore be recommended when a screening result requires clarification.

In the UK, newborn screening can include the NHS newborn blood spot test, commonly known as the heel prick test. This screening uses a small blood sample taken from a baby’s heel to look for specific serious conditions. The conditions included in standard screening depend on the national programme and can change as screening policies and evidence develop.

Additional genetic testing may sometimes be considered when there is a relevant family history, a concerning screening result or clinical information suggesting that further investigation could be useful. The appropriate approach depends on the baby’s individual circumstances and the specific clinical question being considered.

The purpose of Newborn Genetic Screening is therefore not to provide a complete genetic assessment of a baby. Instead, it is designed to identify specific conditions or potential risks at an early stage, when timely follow-up may make an important difference to care.

Why Is Newborn Genetic Screening Important

Why Is Newborn Genetic Screening Important?

Newborn Genetic Screening can help identify certain serious conditions at an early stage, sometimes before a baby develops noticeable symptoms. Early identification gives healthcare professionals an opportunity to arrange further testing, assessment and treatment when needed.

Some inherited and metabolic conditions can affect a baby’s health if they are not recognised early. Screening helps identify babies who may need closer assessment, allowing appropriate care to begin as soon as possible.

Newborn screening can also provide reassurance when no further assessment is needed. However, it is important to remember that screening is not a diagnosis. A result suggesting a possible condition usually requires further testing to confirm whether the condition is actually present.

What Conditions Can Newborn Screening Detect?

In England, the NHS newborn blood spot test screens for 10 rare but serious conditions. Early identification can allow further assessment and treatment to begin promptly when needed.

Condition What It Affects Type
Sickle Cell Disease Red blood cells and oxygen delivery Inherited blood condition
Cystic Fibrosis Breathing, digestion and growth Inherited condition
Congenital Hypothyroidism Thyroid hormone production Endocrine condition
Phenylketonuria (PKU) The body's processing of phenylalanine Inherited metabolic condition
MCADD How the body uses certain fats for energy Inherited metabolic condition
Maple Syrup Urine Disease (MSUD) How the body processes certain amino acids Inherited metabolic condition
Isovaleric Acidaemia (IVA) Processing of certain proteins Inherited metabolic condition
Glutaric Aciduria Type 1 (GA1) Processing of certain amino acids Inherited metabolic condition
Homocystinuria (HCU) Processing of certain amino acids Inherited metabolic condition
Hereditary Tyrosinaemia Type 1 (HT1) Processing of tyrosine Inherited metabolic condition

Newborn screening is not a diagnostic test. If screening suggests that a baby may have a condition, further assessment and diagnostic testing may be needed to confirm the result.

What Is the NHS Newborn Blood Spot Test?

The NHS newborn blood spot test, commonly known as the heel prick test, is a routine screening test offered to newborn babies in England. It uses a few drops of blood taken from the baby’s heel to screen for certain serious inherited, metabolic and other health conditions.

The sample is usually taken when a baby is around five days old. The blood is sent to a laboratory, where it is checked for markers associated with the conditions included in the NHS newborn screening programme.

The test is designed to identify babies who may need further assessment. It does not usually confirm that a baby has a particular condition. If a screening result is outside the expected range, healthcare professionals will explain the next steps, which may include further testing.

For a more detailed explanation of how the test is performed and what parents can expect, see our Complete Guide to the Newborn Heel Prick Test.

How Does Newborn Genetic Screening Work?

Newborn screening follows a simple process, from collecting a small blood sample to reviewing the result and arranging further assessment when needed.

Stage What Happens Purpose
1. Sample Collection A small blood sample is taken from the baby's heel. To obtain a sample for screening.
2. Laboratory Analysis The sample is analysed for markers associated with the conditions included in the screening programme. To identify results that may need further investigation.
3. Result Review The screening result is reviewed and classified according to the programme's criteria. To determine whether further assessment may be needed.
4. Further Assessment If a result requires follow-up, healthcare professionals arrange appropriate assessment or diagnostic testing. To establish whether a condition is actually present.
5. Clinical Follow-Up Where a condition is confirmed, the baby can receive appropriate specialist care or monitoring. To support timely management and ongoing care.

Newborn screening is a screening process, not a diagnosis. Its role is to identify babies who may need further assessment so that appropriate next steps can be taken promptly.

When Is Newborn Screening Performed?

The NHS newborn blood spot test is usually offered when a baby is around five days old. A small blood sample is taken from the baby’s heel and sent to a laboratory for screening.

The timing is important because some conditions may not be apparent immediately after birth. Screening at this stage can help identify babies who may need further assessment before symptoms develop.

If the test cannot be completed at the usual time, healthcare professionals can advise parents on when it should be carried out. The appropriate timing may vary depending on the baby’s circumstances.

What Happens After a Newborn Screening Test?

After the screening test, the result is reviewed to determine whether any further assessment is needed. Most babies will not need additional testing.

🩸

Screening Sample Is Analysed

The blood sample is analysed for markers linked to the conditions included in the screening programme.

📋

Result Is Reviewed

The result is assessed to determine whether it is within the expected range or needs follow-up.

✓

No Further Action

If the result does not suggest a concern, no further testing may be needed through the screening programme.

🔍

Further Assessment

If a result suggests a possible condition, healthcare professionals may arrange further assessment or diagnostic testing.

👩‍⚕️

Clinical Follow-Up

If a condition is confirmed, the baby can be referred for appropriate specialist care, treatment or monitoring.

A screening result does not usually confirm a diagnosis. Further testing may be needed to understand what the result means.

What Do Newborn Screening Results Mean?

Newborn screening results show whether a baby may need further assessment. A screening result does not usually confirm or rule out a condition on its own.

Result What It Means Possible Next Step
No Concern Identified The screening result does not suggest one of the conditions being screened for. Usually no further action is needed through the screening programme.
Further Testing Recommended The result suggests that the baby may have the condition being screened for. Further assessment or diagnostic testing may be arranged.
Repeat Sample Needed The original sample may not have provided a clear result or may need to be checked again. A new sample may be requested.
Condition Confirmed Diagnostic testing has established that the baby has the condition. Appropriate specialist care, treatment or monitoring can be arranged.

A screening result is not the same as a diagnosis. If a result raises a concern, further testing is used to establish whether a condition is actually present.

What Are the Limitations of Newborn Genetic Screening?

Newborn Genetic Screening is useful for identifying certain conditions early, but it does not provide a complete picture of a baby’s health or genetics.

Screening only looks for the specific conditions included in the programme. A normal result does not mean that a baby is free from all genetic or health conditions.

Screening can also produce results that need further investigation. A result suggesting a possible condition does not usually confirm a diagnosis, so additional testing may be needed.

The timing and accuracy of screening can also be affected by factors such as when the sample is collected or the baby’s individual circumstances. Healthcare professionals can advise when further assessment is appropriate.

How Is Newborn Screening Different From Other Genetic Tests?

Newborn screening is designed to identify babies who may need further assessment, while other genetic tests are usually used to investigate a specific clinical question or confirm a suspected condition.

Aspect Newborn Screening Other Genetic Tests
Main Purpose To identify babies who may have certain screened conditions. To investigate a specific genetic or clinical question.
When It Is Used Shortly after birth as part of a screening programme. When there is a relevant clinical reason or specific concern.
What It Examines Specific markers associated with conditions included in the screening programme. Specific genes, variants, chromosomes or wider genetic information, depending on the test.
Result Indicates whether further assessment may be needed. May help confirm, exclude or investigate a particular genetic condition.
Diagnostic Role It is a screening test and does not usually provide a diagnosis. Some genetic tests can be used to confirm a diagnosis when clinically appropriate.

Newborn screening and genetic testing can serve different purposes. Screening identifies babies who may need further investigation, while diagnostic genetic testing can help answer a specific clinical question.

Can Newborn Genetic Screening Be Expanded Beyond Standard Screening?

Newborn Genetic Screening can potentially be expanded beyond the conditions included in standard screening programmes. Advances in genomic testing, including whole genome sequencing, are being studied to determine whether a wider range of rare genetic conditions can be identified earlier in life.

In the UK, research programmes are exploring whether genomic screening could complement existing newborn screening by identifying additional conditions where early diagnosis and treatment may improve outcomes. However, expanded genomic screening is not the same as the standard NHS newborn blood spot screening programme.

Any expanded approach requires careful consideration of which conditions are suitable for screening, how genetic findings should be interpreted and what follow-up or confirmatory testing may be needed. The scope and availability of expanded newborn screening may therefore change as clinical evidence and screening programmes develop.

Who May Consider Additional Genetic Testing for a Newborn?

Additional genetic testing may be considered when standard newborn screening does not fully explain a clinical concern or when there is a specific reason to investigate a possible genetic condition.

A Relevant Family History

A known genetic condition or relevant pattern of inherited disease in the family may lead healthcare professionals to consider further genetic assessment.

A Concerning Screening Result

A newborn screening result that requires follow-up may lead to additional testing to determine whether a condition is actually present.

Unexplained Clinical Findings

Certain unexplained signs, symptoms or clinical findings may prompt a healthcare professional to investigate a possible genetic cause.

A Known Familial Genetic Variant

If a specific genetic variant is already known in the family, targeted testing may sometimes be considered to determine whether the newborn has inherited it.

Additional genetic testing is not routinely required for every newborn. The decision depends on the baby's clinical circumstances, family history and any findings from previous screening or assessment. Where appropriate, a healthcare professional can advise whether further genetic investigation may be useful.

Frequently Asked Questions

What is newborn genetic screening?

Newborn genetic screening is used shortly after birth to identify certain inherited, metabolic and other serious conditions before symptoms may become apparent. It is a screening process and does not usually provide a diagnosis.

The NHS newborn blood spot test, also known as the heel prick test, uses a small blood sample taken from a baby’s heel to screen for specific conditions included in the national screening programme.

The test is usually offered when a baby is around five days old. Healthcare professionals can advise on the appropriate timing if the test cannot be completed at the usual time.

No. Newborn screening only covers specific conditions included in the relevant screening programme. A normal screening result does not rule out all genetic or health conditions.

Not necessarily. A screening result that requires follow-up indicates that further assessment may be needed. Confirmatory testing may be required before a diagnosis can be established.

Expanded newborn genomic screening is being studied to determine whether additional genetic conditions could be identified earlier in life. This is separate from standard NHS newborn blood spot screening.

Additional genetic testing may be considered when there is a relevant family history, a concerning screening result, unexplained clinical findings or a known genetic variant in the family. The appropriate approach depends on the individual circumstances.

No. Screening identifies babies who may need further assessment, while diagnostic genetic testing is used to investigate a specific clinical question or suspected condition.

Healthcare professionals will explain the result and arrange appropriate follow-up. This may include repeat screening, clinical assessment or diagnostic testing, depending on the circumstances.

Newborn Genetic Screening at London Genetics

Newborn Genetic Screening can help identify certain inherited and metabolic conditions early in life. Where additional genetic assessment may be relevant, the appropriate approach depends on the baby's clinical findings, family history and any previous screening results.

What We Consider

Clinical Information: Relevant medical findings, family history and the reason for considering genetic testing are taken into account when assessing whether further investigation may be appropriate.

Previous Screening: Existing newborn screening results can help determine whether further assessment or diagnostic testing may be appropriate.

Appropriate Testing: Where additional testing is considered, the choice of test depends on the specific clinical question and the genetic information that needs to be investigated.

Why London Genetics?

At London Genetics, we take a personalised approach to genetic assessment, considering each baby's individual circumstances rather than treating genetic testing as a one-size-fits-all process.

We can help explain the purpose and limitations of genetic testing and discuss what different results may mean. Where further investigation is appropriate, the next steps can be considered in the context of the available clinical and family information.

If you have questions about newborn genetic screening or are considering additional genetic testing for your baby, arrange a consultation with London Genetics to discuss your circumstances and available options.

Book a Consultation

Leave a Reply

Your email address will not be published. Required fields are marked *


Dr. Ehsan Karimiani
Book Your Genetic Consultation

At London Genetics, booking your consultation couldn’t be simpler. Dr Ehsan Karimiani will take the time to listen, understand your background, and guide you through the right genetic testing or counselling options for you.

Whether you’re curious about how your DNA affects your health, medication response, or family risks, we’ll help you make informed choices with clarity and care.

Choose a time that suits your schedule — and start your journey towards truly personalised healthcare.